Cargando…

Rhamnogalacturonan II is a Toll-like receptor 4 agonist that inhibits tumor growth by activating dendritic cell-mediated CD8(+) T cells

We evaluated the effectiveness of rhamnogalacturonan II (RG-II)-stimulated bone marrow-derived dendritic cells (BMDCs) vaccination on the induction of antitumor immunity in a mouse lymphoma model using EG7-lymphoma cells expressing ovalbumin (OVA). BMDCs treated with RG-II had an activated phenotype...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Sung Nam, Tae Noh, Kyung, Jeong, Young-Il, Duk Jung, In, Kyu Kang, Hyun, Sun Cha, Gil, Jung Lee, Su, Keun Seo, Jong, Hwan Kang, Dae, Hwang, Tae-Ho, Kyung Lee, Eun, Kwon, Byungsuk, Park, Yeong-Min
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2013
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3584663/ https://www.ncbi.nlm.nih.gov/pubmed/23392255 http://dx.doi.org/10.1038/emm.2013.14

Ejemplares similares

The Mycobacterium avium subsp. paratuberculosis fibronectin attachment protein, a toll-like receptor 4 agonist, enhances dendritic cell-based cancer vaccine potency
por: Noh, Kyung Tae, et al.
Publicado: (2012)

The Mycobacterium avium subsp. Paratuberculosis protein MAP1305 modulates dendritic cell-mediated T cell proliferation through Toll-like receptor-4
por: Lee, Su Jung, et al.
Publicado: (2014)

Mycobacterium abscessus MAB2560 induces maturation of dendritic cells via Toll-like receptor 4 and drives Th1 immune response
por: Lee, Su Jung, et al.
Publicado: (2014)

Toll-like receptor 3-induced immune response by poly(d,l-lactide-co-glycolide) nanoparticles for dendritic cell-based cancer immunotherapy
por: Han, Hee Dong, et al.
Publicado: (2016)

Enhancement of paclitaxel-induced breast cancer cell death via the glycogen synthase kinase-3β-mediated B-cell lymphoma 2 regulation
por: Noh, Kyung Tae, et al.
Publicado: (2016)

Deoxypodophyllotoxin Induces a Th1 Response and Enhances the Antitumor Efficacy of a Dendritic Cell-based Vaccine
por: Lee, Jun Sik, et al.
Publicado: (2011)

Neoagarohexaose-mediated activation of dendritic cells via Toll-like receptor 4 leads to stimulation of natural killer cells and enhancement of antitumor immunity
por: Lee, Moon Hee, et al.
Publicado: (2017)

Herbal preparation (HemoHIM) enhanced functional maturation of bone marrow-derived dendritic cells mediated toll-like receptor 4
por: Lee, Sung-Ju, et al.
Publicado: (2016)

Outer membrane protein a of Salmonella enterica serovar Typhimurium activates dendritic cells and enhances Th1 polarization
por: Lee, Jun Sik, et al.
Publicado: (2010)

Resveratrol regulates naïve CD 8(+) T-cell proliferation by upregulating IFN-γ-induced tryptophanyl-tRNA synthetase expression
por: Noh, Kyung Tae, et al.
Publicado: (2015)

Mycobacterium abscessus ᴅ-alanyl-ᴅ-alanine dipeptidase induces the maturation of dendritic cells and promotes Th1-biased immunity
por: Lee, Seung Jun, et al.
Publicado: (2016)

A novel TLR4 binding protein, 40S ribosomal protein S3, has potential utility as an adjuvant in a dendritic cell-based vaccine
por: Park, Hyun Jin, et al.
Publicado: (2019)

Regulation of toll-like receptors expression in muscle cells by exercise-induced stress
por: Park, Jeong-Woong, et al.
Publicado: (2021)

Pancreatic adenocarcinoma upregulated factor serves as adjuvant by activating dendritic cells through stimulation of TLR4
por: Kang, Tae Heung, et al.
Publicado: (2015)

Synthetic TGF-β Signaling Agonist-Treated Dendritic Cells Induce Tolerogenicity and Antirheumatic Effects
por: Oh, Ji-Soo, et al.
Publicado: (2022)

Rhamnogalacturonan‐I is a determinant of cell–cell adhesion in poplar wood
por: Yang, Haibing, et al.
Publicado: (2019)

Dendritic cell vaccination with a toll-like receptor agonist derived from mycobacteria enhances anti-tumor immunity
por: Vo, Manh-Cuong, et al.
Publicado: (2015)

Natural toll-like receptor agonists in prophylactic vaccines for dendritic cell activation
por: Peng, Paul, et al.
Publicado: (2015)

A Potential Protein Adjuvant Derived from Mycobacterium tuberculosis Rv0652 Enhances Dendritic Cells-Based Tumor Immunotherapy
por: Lee, Seung Jun, et al.
Publicado: (2014)

Synthesis of borate cross-linked rhamnogalacturonan II
por: Funakawa, Hiroya, et al.
Publicado: (2015)

Activation of Dendritic Cells by the Novel Toll-Like Receptor 3 Agonist RGC100
por: Naumann, Kai, et al.
Publicado: (2013)

Ubiquitination of MAP1LC3B by pVHL is associated with autophagy and cell death in renal cell carcinoma
por: Kang, Hyun Mi, et al.
Publicado: (2019)

Threonyl-tRNA Synthetase Promotes T Helper Type 1 Cell Responses by Inducing Dendritic Cell Maturation and IL-12 Production via an NF-κB Pathway
por: Jung, Hak-Jun, et al.
Publicado: (2020)

Nanoparticle-Based Vaccine Delivery for Cancer Immunotherapy
por: Park, Yeong-Min, et al.
Publicado: (2013)

Structural characteristics of a red ginseng acidic polysaccharide rhamnogalacturonan I with immunostimulating activity from red ginseng
por: Lee, Sue Jung, et al.
Publicado: (2020)

Toll-Like Receptors in Natural Killer Cells and Their Application for Immunotherapy
por: Noh, Ji-Yoon, et al.
Publicado: (2020)

Integrin β-like 1 protein (ITGBL1) promotes cell migration by preferentially inhibiting integrin-ECM binding at the trailing edge
por: Jang, Dong Gil, et al.
Publicado: (2022)

Rhamnogalacturonan-I Based Microcapsules for Targeted Drug Release
por: Svagan, Anna J., et al.
Publicado: (2016)

The Novel Role of Platelet-Activating Factor in Protecting Mice against Lipopolysaccharide-Induced Endotoxic Shock
por: Jeong, Young-Il, et al.
Publicado: (2009)

Circulating Plasmacytoid and Conventional Dendritic Cells Are Numerically and Functionally Deficient in Patients With Scrub Typhus
por: Kang, Seung-Ji, et al.
Publicado: (2021)

Efficiency of Interferon-γ in Activating Dendritic Cells and Its Potential Synergy with Toll-like Receptor Agonists
por: Bian, Yuanzhi, et al.
Publicado: (2023)

Diversity of Pectin Rhamnogalacturonan I Rhamnosyltransferases in Glycosyltransferase Family 106
por: Wachananawat, Bussarin, et al.
Publicado: (2020)

Proportion of peripheral regulatory T cells in patients with autoimmune encephalitis
por: Byun, Jung-Ick, et al.
Publicado: (2021)

The Novel Toll-Like Receptor 2 Agonist SUP3 Enhances Antigen Presentation and T Cell Activation by Dendritic Cells
por: Guo, Xueheng, et al.
Publicado: (2017)

Interactions between tumor-derived proteins and Toll-like receptors
por: Jang, Gun-Young, et al.
Publicado: (2020)

Dendritic Cell Activation by Glucan Isolated from Umbilicaria Esculenta
por: Kim, Hyung Sook, et al.
Publicado: (2010)

Properties regulating the nature of the plasmacytoid dendritic cell response to Toll-like receptor 9 activation
por: Guiducci, Cristiana, et al.
Publicado: (2006)

GM-CSF-loaded chitosan hydrogel as an immunoadjuvant enhances antigen-specific immune responses with reduced toxicity
por: Noh, Kyung Hee, et al.
Publicado: (2014)

Effect of Choline Alphoscerate on the Survival of Glioblastoma Patients: A Retrospective, Single-Center Study
por: Kim, Yeong Jin, et al.
Publicado: (2022)

Prognostic significance of E-cadherin and N-cadherin expression in Gliomas
por: Noh, Myung-Giun, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_uq7m59i1rsuf6l3s1126d7vu3g